SynthesisInterdisciplinary cardiovascular and thoracic surgery2026
3D Printing for Mitral Valve Disease: A Systematic Review.
Synthesis in Interdisciplinary cardiovascular and thoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivesMitral valve disease remains one of the most prevalent and complex cardiac conditions, with treatment strategies varying based on anatomical and pathological factors. The heterogeneity in mitral valve morphology complicates standardized treatment, highlighting the importance of procedural planning and surgical training. This systematic review evaluates current techniques, materials, and clinical applications of 3D printing in mitral valve disease, with a focus on procedural planning and simulation.
methodsA comprehensive literature search of PubMed and MEDLINE databases was conducted to identify studies published from 1996 to August 2025. A total of 63 studies were included, all involving 3D printing technologies related to mitral valve disease. Extracted data covered imaging modalities, software tools, printing techniques, materials used, total time required for model creation, and clinical applications.
resultsCT, 3D transoesophageal echocardiography, and MRI were the main imaging modalities, with CT being the most common. Data segmentation and model generation were performed using software such as Mimics, 3D Slicer, and Philips QLAB. The primary 3D printing techniques were stereolithography, fused deposition modelling, and PolyJet, using photopolymer resins and thermoplastics. Total processing time-from image acquisition to model completion-ranged from 45 min to 72 h, depending on complexity. Applications included procedural planning, surgical training, and the development of medical and simulation-based educational devices.
conclusions3D printing enhances mitral valve surgery by enabling precise planning and training. Although challenges like standardization and accessibility persist, advances in imaging, software, and materials are expected to expand its clinical impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.